-
Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care
16 Apr 2024 07:27 GMT
… : Two-drug regimens (2DR) may address drug–drug interactions and … alleviate concerns of drug–drug interactions and antiretroviral toxicity … AIDS Healthcare Foundation, EMD Serono, Gilead Sciences, Janssen … www.fda.gov/drugs/human-immunodeficiency-virus …
-
Caris Life Sciences Partner with Merck to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development
04 Apr 2024 17:37 GMT
… its healthcare business as EMD Serono in the U.S. and … of first-in-class antibody-drug conjugates (ADC) for cancer patients … the development and commercialization of drug candidates emanating from these programs …
-
Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development
04 Apr 2024 11:04 GMT
… healthcare business as EMD Serono in the U.S. … development and commercialization of drug candidates emanating from … monitoring, therapy selection and drug development.
Headquartered in Irving, … first-in-class-antibody-drug-conjugate-development-302107754. …
-
Multiple Sclerosis Drugs Market Projected to Reach $34.36 Bn by 2030, Flourishing at a CAGR of 3.60%
02 Apr 2024 07:25 GMT
… Companies in Global Multiple Sclerosis Drugs Market
• Celgene Corporation
… (Johnson & Johnson)
• EMD Serono (Merck KGaA)
• Bayer AG
• … Drugs Market Segmentation
By Drug Class
• Immunosuppressants
• Immunomodulators
• Interferons
• Other Drug …
-
FDA Approved Drug Products Approval List March 2024
30 Mar 2024 10:39 GMT
Approval Date Drug Name Submission Active Ingredients Company … #761049 SUPPL-16 AVELUMAB EMD SERONO INC Approval 03/06 …
-
Infant Exposure to MS Drugs via Breastfeeding: New Data
12 Mar 2024 12:43 GMT
… be important to know whether drugs administered monthly, such as natalizumab … GmbH Germany, Hexal AG, Merck Serono GmbH, Novartis Pharma GmbH, Roche …
-
Blockbuster BeiGene Cancer Drug Adds Another FDA Approval
10 Mar 2024 13:09 GMT
… and Leqembi, antibody drugs that previously won approvals … following eye surgery. The drug, clobetasol propionate ophthalmic suspension … technology.
The Formosa drug will be commercialized in … progression-free survival.
—EMD Serono, the healthcare business of …
-
EMD Serono Presents New MAVENCLAD® Data Supporting Cognitive Function Benefits
29 Feb 2024 13:14 GMT
… lymphopenia.
Drug Interactions: Concomitant use of with immunosuppressive or myelosuppressive drugs and … the science.
About EMD Serono, Inc.
EMD Serono - the healthcare business … MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics …
-
Is Metformin a 'Drug for All Diseases'?
27 Feb 2024 07:39 GMT
… among the most widely prescribed drugs in the United States. … cardiovascular outcomes trial of the drug.
Gregory G. Schwartz, MD … antihyperglycemic and insulin-sensitizing drug, or result from other … and matching placebo from EMD Serono, a subsidiary of Merck, …
-
FDA expands label for Novartis and Roche's blockbuster, converts EMD Serono's NSCLC drug to full approval
16 Feb 2024 21:08 GMT
… for EMD Serono’s non-small cell lung cancer drug Tepmetko (tepotinib …